Biology subjects

Coughlin, M. F.

Publications and source records attributed to Coughlin, M. F..

3 recordsLinked to original sources

bioRxiv2025

Measuring Perfusion Pressure and Flow Resistance in a Microfluidic Device Using an External Optical System

The pathology of human diseases are now investigated using microphysiological systems (MPS) supporting vascular structures. Efforts to increase physiological relevance of these platforms have centered on the incorporation of organ-specific cellular and non-cellular constituents. However, tissue-specific cellular constituents must experience appropriate physical forces to faithfully replicate physiological function. Quantification of physical forces in MPS has received little attention. The goal of this study was to establish a simple and robust system capable of interfacing with existing pumps to quantitatively characterize the flow delivered to a MPS. The system assessed both the fluid pressure driving flow through a microphysiological platform and the resistance to flow of glass capillary tubes or a model vascular network. The system showed excellent qualitative and quantitative agreement with resistance values measured by a hydrostatic approach and predicted for laminar flow through a smooth capillary tube. Importantly, the system is optically-based without sensors contacting the circulating fluid making it ideally-suited for long-term biological studies where sterility is paramount. Benchmarking experiments were supplemented with measurements of driving pressure and flow resistance from vascular structures within a MPS in a humidified incubator. Vascular resistance measurements were consistent with published results obtained from similar microvascular networks.

bioengineering↗

bioRxiv2025

ETV2 mediated differentiation of human pluripotent stem cells results in functional endothelial cells for engineering advanced vascularized microphysiological models

Patient-specific microphysiological models, exemplified by organs-on-a-chip and organoids, have become a valuable tool for broad applications, revolutionizing biomedical research. However, limitations persist, with functional vasculature being a significant challenge. Generating functional human induced pluripotent stem cell (h-iPSC) derived endothelial cells (h-iECs) represent an urgent need. With the discovery of ETV2s determinant role in specifying EC lineages during differentiation, researchers have adopted techniques involving ETV2 overexpression to produce h-iECs more efficiently and consistently. However, the capacity of these cells to form functional vasculatures has not yet been thoroughly investigated. Here, we generated multiple h-iPSC lines with inducible ETV2 expression, and subsequently differentiated them into h-iECs, which were validated functionally and by key endothelial markers and RNA-seq analysis. These cells are capable of self-organizing into stable microvascular networks (MVNs) in a microfluidic chip reproducibly, forming lumenized and functional vessels that mimic the in vivo capillary bed in both morphology and function - a result not achieved using h-iECs differentiated with conventional two-step methods using the same h-iPSC lines. Furthermore, complex microphysiological models featuring perfusable vasculature were also successfully developed using ETV2 activated h-iECs, demonstrated with vascularized tumor and blood-brain barrier (BBB) models. Additionally, by pooling genetically engineered h-iPSCs with inducible ETV2, we effectively employed an orthogonally induced differentiation approach to enhance vascularization of an organoid model. Our methodology opens avenues in precision medicine, leading to personalized microphysiological models with perfusable vasculature for various applications.

bioengineering↗

bioRxiv2023

Patient-Specific Vascularized Tumor Model: Blocking TAM Recruitment with Multispecific Antibodies Targeting CCR2 and CSF-1R

Tumor-associated inflammation drives cancer progression and therapy resistance, with the infiltration of monocyte-derived tumor-associated macrophages (TAMs) associated with poor prognosis in diverse cancers. Targeting TAMs holds potential against solid tumors, but effective immunotherapies require testing on immunocompetent human models prior to clinical trials. Here, we develop an in vitro model of microvascular networks that incorporates tumor spheroids or patient tissues. By perfusing the vasculature with human monocytes, we investigate monocyte trafficking into the tumor and evaluate immunotherapies targeting the human tumor microenvironment. Our findings demonstrate that macrophages in vascularized breast and lung tumor models can enhance monocyte recruitment via TAM-produced CCL7 and CCL2, mediated by CSF-1R. Additionally, we assess a novel multispecific antibody targeting CCR2, CSF-1R, and neutralizing TGF-{beta}, referred to as CSF1R/CCR2/TGF-{beta} Ab, on monocytes and macrophages using our 3D models. This antibody repolarizes TAMs towards an anti-tumoral M1-like phenotype, reduces monocyte chemoattractant protein secretion, and effectively blocks monocyte migration. Finally, we show that the CSF1R/CCR2/TGF-{beta} Ab inhibits monocyte recruitment in patient-specific vascularized tumor models. Overall, this vascularized tumor model offers valuable insights into monocyte recruitment and enables functional testing of innovative therapeutic antibodies targeting TAMs in the tumor microenvironment (TME).

bioengineering↗